Key result
Mass spectrometry analysis identified 58 significantly different proteins in perivascular adipose tissue between donors with and without advanced coronary artery disease.
Why the study?
Perivascular adipose tissue exerts a paracrine effect on blood vessels, and its molecular signatures related to cardiovascular disease needed to be understood.
Are there distinct cellular characteristics and protein signatures in perivascular adipose tissue of patients with advanced coronary artery disease compared to those without?
Observational (n=54)
Are there distinct cellular characteristics and protein signatures in perivascular adipose tissue of patients with advanced coronary artery disease compared to those without?
Multiscale anisotropy and proteomic profiling of perivascular adipose tissue can distinguish between patients with and without advanced coronary artery disease, highlighting potential molecular signatures of cardiovascular disease.
Perivascular adipose tissue protein differences associate with advanced CAD; hypothesis-generating and requires prospective validation before clinical use.
Background/Objectives: Perivascular adipose tissue (PVAT) exerts a paracrine effect on blood vessels and our objective was to understand PVAT molecular signatures related to cardiovascular disease. Methods: We studied two groups: those undergoing mitral valve repair/replacement (VR, n = 16) and coronary artery bypass graft (CABG, n = 38). VR donors did not have coronary artery disease, whereas CABG donors had advanced coronary artery disease. Clinical and tissue pathologies and proteomics from adipose tissue were assessed. Results: Donors undergoing VR had a lower body mass index (p = 0.01), HbA1C (p = 0.0023), and incidence of diabetes (p = 0.022) compared to CABG. VR donors were overall healthier, with higher cardiac function compared to CABG donors, based on ejection fraction. Although adipose histopathology between groups was not markedly different, PVAT had smaller and more adipocytes compared to subcutaneous adipose tissues. These differences were validated by whole specimen automated morphological analysis, and anisotropy analysis showed small (2.8–7.5 μm) and large (22.8–64.4 μm) scale differences between perivascular and subcutaneous adipose tissue from CABG donors, and small scale changes (2.8–7.5 μm) between perivascular and subcutaneous adipose tissue from VR donors. Distinct protein signatures in PVAT and subcutaneous adipose tissue include those involved in secretion, exosomes and vesicles, insulin resistance, and adipocyte identity. Comparing PVAT and subcutaneous adipose tissue from CABG donors, there were 82 significantly different proteins identified with log fold change ≥ 0.3 or ≤−0.3 (p < 0.05). Using this threshold, there were 36 differences when comparing PVAT and subcutaneous adipose tissue from VR donors, 58 differences when comparing PVAT from CABG or VR donors, and 55 when comparing subcutaneous adipose tissue from CABG vs. VR donors. Conclusions: Routine histopathology cannot differentiate between PVAT from donors with or without coronary artery disease, but multiscale anisotropy analysis discriminated between these populations. Our mass spectrometry analysis identified a cohort of proteins that distinguish between adipose depots, and are also associated with the presence or absence of coronary artery disease.
No takes yet. Share an insight, caveat, or question.
Tero et al. (2024) conducted an observational in Advanced coronary artery disease (n=54). Advanced coronary artery disease vs. No coronary artery disease was evaluated on Protein signatures in perivascular adipose tissue. Mass spectrometry analysis identified 58 significantly different proteins in perivascular adipose tissue between donors with and without advanced coronary artery disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: